Skip to content
Close

Regenerative

Exosome Therapy in Miami

Exosomes are extracellular vesicles that carry signaling molecules between cells. No exosome product is FDA-approved for any use, and the FDA has warned patients about unapproved exosome products. This page explains their regulatory status and the evidence, so you can evaluate any offer you receive.

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Last updated:

Key takeaways

  • There are no FDA-approved exosome products for any therapeutic use.
  • The FDA issued a public safety notification in 2019 after adverse events from unapproved exosome preparations.
  • Human evidence is limited to small case series and early studies.
  • Product characterization varies by supplier, so documentation review is essential.
  • If any clinic offers you an exosome product, ask whether it is part of a registered clinical trial with an IND number.

What exosome therapy actually is

Exosomes are nanoscale extracellular vesicles, roughly 30 to 150 nanometres across, that cells release to communicate with one another. They carry proteins, lipids and RNA, and in laboratory models they influence how tissue repairs itself. That is legitimately interesting science.

It is also, at present, science rather than approved treatment. There are no FDA-approved exosome products for any therapeutic use, and the agency has issued public safety notifications and warning letters on exactly this point. We tell patients that first, before anything else.

How to evaluate an exosome offer

  1. Ask for the product's regulatory classification.
  2. Ask whether it is part of a registered clinical trial, with NCT and IND numbers.
  3. Ask for lot-specific sterility and characterization data.
  4. Ask what happens if you have a reaction.
  5. Compare it with options that have stronger evidence.

Who should be especially cautious

Who should be especially cautious: anyone offered an exosome product for a serious condition where proven treatment exists, anyone who is pregnant or breastfeeding, and anyone with active cancer or infection. Ask for the product's regulatory status and an IND number before agreeing to anything.

If you have been offered an exosome product

If you have been offered an exosome product elsewhere, we can review the offer with you, along with options that have stronger evidence.

Safety, side effects and contraindications

Reported local effects include injection-site redness, swelling and tenderness. The more significant risk is product quality: the FDA issued a public safety notification in 2019 after serious adverse events in patients who received unapproved preparations marketed as exosomes.

No exosome product is FDA-approved to diagnose, treat, cure or prevent any disease.

Pricing and insurance

Exosome products are not covered by insurance and are often sold at four- and five-figure prices. Ask for a written, itemized price and what is included before you decide anywhere.

Exosomes in South Florida: what to know before you pay

Exosomes are among the most aggressively marketed treatments in South Florida, frequently at four- and five-figure prices. Our role at 3661 S. Miami Ave is to give you the regulatory and scientific picture accurately, and to make sure any decision you reach is an informed one.

Evidence

What the research says

Peer-reviewed sources, quoted directly, including where the evidence is thin.

  • In 2019, the FDA issued a Public Safety Notification on exosome products after serious adverse events were reported in patients who received unapproved preparations marketed as exosomes.

    Regulatory, ethical, and clinical barriers to exosome use in interventional pain medicine. Interventional Pain Medicine, 2026.

    The same paper documents warning letters to clinics selling umbilical cord–derived exosomes without an IND or BLA.

  • Given the classification of exosomes as biological drugs by the FDA, they are subjected to exhaustive evaluation.

    Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine, 2024.

    Why isolation protocols and regulatory pathways remain the field's bottleneck.

  • Human data are limited to small case reports, such as a two-patient report in alopecia areata. Case reports cannot show that a treatment works or is safe.

    Adipose Tissue–Derived Exosomes as a Novel Therapeutic Approach for Refractory Alopecia Areata: A Report of Two Cases, 2025.

    Two patients. That is the scale of the human evidence, and it is nowhere near sufficient to establish efficacy or safety.

Our position

The underlying biology deserves serious research. Until that research produces approved products, exosomes remain unapproved and unproven, and we discuss them on that basis.

Frequently asked questions

In-clinic in Coconut Grove and via telehealth across Florida · (305) 930-8891

Exosomes are not cells. They are vesicles released by cells that carry signaling molecules. No exosome product is FDA-approved for any use.

No. There are zero FDA-approved exosome products for any therapeutic use, and the FDA has issued public safety notifications and warning letters about products marketed as exosomes.

We explain the regulatory status and the evidence, and the options that have stronger evidence for your goal.

Published human data are limited to small case series and early studies, largely in dermatology and hair restoration. There are no large randomized trials supporting general regenerative use.

Ask for the product's regulatory classification, whether it is part of a registered clinical trial, and for lot-specific characterization, sterility and potency data. If a clinic cannot answer precisely, that is your answer.

Local reactions are the most common. The greater risk is unknown product quality; serious adverse events have been reported with unapproved preparations.

Because patients ask, and because they are better served hearing the regulatory reality from a physician than from an advertisement.

Possibly. Legitimate research is progressing through proper channels. Approval requires trials that have not yet been completed.

No.

Depending on your goal: structured rehabilitation, hormone and metabolic optimization, sleep and recovery work, or established dermatological treatments. We will name them.

Regulatory note: no exosome product is FDA-approved for any use. This page is general information, not an offer of treatment.

Contact

Send us a message

Share a few details and our team will reach out within one business day.

What happens next

  1. Our team reaches out within one business day to understand your goals.
  2. We schedule your initial consultation, in clinic or via telehealth.
  3. Your physician builds a personalized plan and we take the first step together.

Visit us

3661 S. Miami Ave, Suite 1003Miami, FL 33133 · United States By appointment · Mon–Fri, 9 AM – 6 PM Care in English, Spanish and French.

Your contact details

I'm interested in

Anything else we should know? (optional)

For example, the best time to call. Please don’t include medical details.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.